The Ordinary identifies stabilized retinaldehyde in a 0.2% emulsion and lists synthetic oat analogues among the key supporting ingredients. The captured US price was $14.90. It is a cosmetic retinal product, not a prescription tretinoin cream.
Retinal’s place in the vitamin A pathway does not yield a reliable percentage conversion to tretinoin. Compare the actual emulsion and current label with another retinal product. The higher-strength language describes The Ordinary’s own range and should not be treated as a universal measure across all retinoids.
Read the actual formulation
The Ordinary identifies stabilized retinaldehyde at 0.2% in an emulsion and synthetic oat analogues among its supporting ingredients. The captured US price was $14.90. This retinal product is a cosmetic formulation, rather than a former prescription service or a tretinoin cream. The practical comparison is a cosmetic 0.2% retinaldehyde emulsion with supporting synthetic oat analogues. The Ordinary Retinal 0.2% Emulsion is listed as non-tretinoin cosmetic retinal. When a complete base or a detail of the selected prescription is not established, confirm it through the current official label or provider instead of filling it from another product.
A useful way to assess this option is to compare it with a product performing the same job. For The Ordinary Retinal 0.2% Emulsion, ask whether the attraction is the named active, the texture, the access route or a particular brand claim. Those reasons lead to different alternatives. A reader satisfied with an existing moisturizer may be choosing a treatment step; a reader mainly concerned about dryness may be deciding whether a separate serum adds anything useful.
Related reading: Tretinoin, retinol and retinal: different routes
The evidence question for this product
The evidence question for The Ordinary Retinal 0.2% Emulsion concerns its finished cosmetic retinal formulation. The current brand source establishes its product identity, disclosed ingredients and attributed claims. It does not make the product prescription tretinoin or confer another medicine’s approved indication or trial results. Read any brand study description for the selected formula and endpoint measured, rather than convert its percentage into a tretinoin dose or assume that a comparison with another retinoid establishes interchangeability.
Routine fit and cautions
For The Ordinary Retinal 0.2% Emulsion, the relevant routine question concerns a cosmetic 0.2% retinaldehyde emulsion with supporting synthetic oat analogues. Read this product’s own label and storage information alongside any acids or other retinoids already in use. Dryness or irritation is a reason to review the routine, rather than assume a higher percentage will improve it. Discuss pregnancy, pregnancy planning or breastfeeding before choosing a retinoid. This cosmetic review does not supply a prescription schedule or establish an equivalent dose of another vitamin A product.
Compare the options in top 5 tretinoin treatment routes or read Tretinoin cream, gel and lotion formats.
Cost and the decision to buy
The source snapshot records $14.90 shown on the brand page. For The Ordinary Retinal 0.2% Emulsion, confirm the actual selected size, quantity and purchase terms on the official page. Compare a retail bottle, a prescription supply and a consultation over the same period; their headline figures are not interchangeable. Subscription or bundle pricing is a separate purchase option, not a reason to assume that more products are necessary.
Our decision point is a cosmetic 0.2% retinaldehyde emulsion with supporting synthetic oat analogues. The information above helps decide what to read next and what needs clarification before purchasing The Ordinary Retinal 0.2% Emulsion. Use the related product review for a specific alternative and the category comparison to see the options together. If the ingredient identity, intended use or cost remains uncertain, the official manufacturer or treating clinician is the appropriate source for that missing detail.
Sources and verification
Official pages establish product facts and provider claims. Clinical and regulatory sources answer separate evidence questions. Checked October 1, 2026. No medical reviewer is credited for this article.